se of Montelukast in acute moderate bronchiolitis.(3 months to 2 years)
- Conditions
- Health Condition 1: J219- Acute bronchiolitis, unspecified
- Registration Number
- CTRI/2019/07/020456
- Lead Sponsor
- Megadeepan S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) Children aged 3 months to 2 years with first episode of wheezing having a prodromal history consistent with upper respiratory tract infection followed by wheezing and/or crackles on auscultation.
2) WANG score 4 to 8.
1) Age greater than 2 years and age less than 3 months.
2) Baby born premature (less than 34 weeks).
3) Previous hospital admission due to any respiratory illness.
4) Previous bronchodilator use before the present illness.
5) Previous steroid use before the present illness.
6) Chronic cardiac or pulmonary disease.
7) History of atopy in child or family.
8) Oxygen saturation <= 85% in room air at the time of recruitment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method